TG02, a novel oral multi-kinase inhibitor of CDKs, JAK2 and FLT3 with potent anti-leukemic properties

K C Goh, V Novotny-Diermayr, S Hart, L C Ong, Y K Loh, A Cheong, Y C Tan, C Hu, R Jayaraman, A D William, E T Sun, B W Dymock, K H Ong, K Ethirajulu, F Burrows, J M Wood
  • Leukemia, August 2011, Springer Science + Business Media
  • DOI: 10.1038/leu.2011.218

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Dr veronica diermayr

In partnership with: